<?xml version="1.0" encoding="UTF-8" standalone="no"?><rss xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:pugpig="http://schema.pugpig.com/rss/" version="2.0">
	<channel>
		<title>Scientific American: Gene Therapy</title> 
		<link>http://www.scientificamerican.com</link>
		<description></description> 
		<image><url>https://static.scientificamerican.com/sciam/assets/Image/newsletter/salogo.png</url><title>Scientific American</title><link>http://www.scientificamerican.com</link></image> 
		<pubDate>Thu, 07 Mar 2024 20:50:59 GMT</pubDate> 
		<language>en-us</language>
		<copyright>Scientific American, a Division of Springer Nature America, Inc.</copyright>
		<itunes:author>Scientific American</itunes:author>
		<itunes:owner><itunes:email>multimedia@sciam.com</itunes:email></itunes:owner>
						<item>
							<title>Sometimes We Can Have Nice Things: Our 10 Favorite Feel-Good Stories of 2023</title>
							<link>https://www.scientificamerican.com/article/sometimes-we-can-have-nice-things-our-10-favorite-feel-good-stories-of-2023/</link>
							<guid isPermaLink="false">5291C02A-4DBE-4D18-8F3B419B537FBA00</guid>
							<pubDate>Thu, 28 Dec 2023 15:00:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Here&amp;rsquo;s the best, most inspiring and coolest science we encountered this year&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Here&amp;rsquo;s the best, most inspiring and coolest science we encountered this year&lt;/p&gt;</description>
			<media:content expression="full" fileSize="3523600" height="496" type="image/jpeg" url="https://static.scientificamerican.com/sciam/cache/file/4D630234-4AD7-4C58-B3AB8983EA056A40_source.jpg" width="790">
				
				<media:credit><![CDATA[Cristina Bencina]]></media:credit>
			</media:content><dc:creator>Sarah Lewin Frasier</dc:creator><category>Biology</category><category>Medicine</category><category>Space &amp; Physics</category><category>Technology</category></item>
						<item>
							<title>The Biggest Health and Medicine Stories of 2023</title>
							<link>https://www.scientificamerican.com/article/the-biggest-health-and-medicine-stories-of-2023/</link>
							<guid isPermaLink="false">BB6CEA4B-B172-408E-8E2EF57DDF6B19EE</guid>
							<pubDate>Tue, 19 Dec 2023 11:45:00 GMT</pubDate>
							<standfirst>&lt;p&gt;From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;From new uses for weight-loss drugs to the first CRISPR gene editing therapy, these were some of the most impactful health stories of the year&lt;/p&gt;</description>
			<media:content expression="full" fileSize="3750015" height="496" type="image/jpeg" url="https://static.scientificamerican.com/sciam/cache/file/B50B19A6-9910-4963-ADF29DE6AA84FA40_source.jpg" width="790">
				<media:description type="html"><![CDATA[In an operating room at the University of Maryland Medical Center on September 20, 2023, surgeons transfer a genetically modified pig heart to the operative field for transplant.]]></media:description>
				<media:credit><![CDATA[University of Maryland School of Medicine]]></media:credit>
			</media:content><dc:creator>Tanya Lewis</dc:creator><category>Biology</category><category>Health</category><category>Medicine</category><category>Public Health</category></item>
						<item>
							<title>FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease</title>
							<link>https://www.scientificamerican.com/article/fda-approves-first-crispr-gene-editing-treatment-for-sickle-cell-disease/</link>
							<guid isPermaLink="false">8BB662CE-DA5E-4AC9-B9E9A14A12D11E9B</guid>
							<pubDate>Fri, 08 Dec 2023 21:15:00 GMT</pubDate>
							<standfirst>&lt;p&gt;Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed&lt;/p&gt;</standfirst>
							<description>&lt;p&gt;Most people with sickle cell disease who received a new gene editing treatment saw their pain resolve for at least one year, but longer follow up is needed&lt;/p&gt;</description>
			<media:content expression="full" fileSize="1737915" height="496" type="image/jpeg" url="https://static.scientificamerican.com/sciam/cache/file/FCBFCDB8-0302-4ABD-A6A18A4ADC6E2B2B_source.jpg" width="790">
				<media:description type="html"><![CDATA[Sickle cell disease causes red blood cells to take on a sickle-like shape, making them fragile and less able to transport oxygen.]]></media:description>
				<media:credit><![CDATA[BSIP SA/Alamy Stock Photo]]></media:credit>
			</media:content><dc:creator>Sara Reardon</dc:creator><category>Biology</category><category>Health</category><category>Medicine</category></item>
	</channel>
</rss>